Eyes On These Biotech & Healthcare
thestreetreports.com/biotech-heal...
#CSDX #RDGL #BSEM #NWBO #NRXBF
0
0
0
0
Hashtag
#BSEM
Advertisement · 728 × 90
0
0
0
0
0
0
0
0
BioStem Technologies (OTC: $BSEM ) reports a 73% YoY revenue increase in Q1 2025, reaching $72.5M. Strong growth in regenerative therapies positions BSEM as a biotech to watch.
#OTCStocks #Biotech #BSEM
1
0
0
0
0
0
0
0
NEWS: ( OTC: #BSEM ) Expected US Company Earnings on Monday, April 14th, 2025
0
0
0
0
0
0
0
0
BREAKING NEWS: ( OTC: #BSEM ) BioStem Technologies Launches Clinical Trial to Demonstrate the Therapeutic Benefits of its BioREtain Technology in Treating Diabetic Foot Ulcers Using Vendaje
0
0
0
0
BREAKING NEWS: ( OTC: #BSEM ) BioStem Technologies Initiates Nationwide Launch of Vendaje AC with Venture Medical Following Established Reimbursement in All Medicare Administrative Contractor (MAC) Regions
#StockMarket #News
1
0
0
0
JUST IN: ( OTC: #BSEM ) BioStem Technologies to Present at the LD Micro Main Event XVII on Wednesday, October 30, 2024, at 9:30 AM PT
#StockMarket #News
1
0
0
0
JUST IN: ( OTC: #BSEM ) BioStem Technologies Establishes National Pricing for Vendaje AC from the Center for Medicare Services and Provides Reimbursement in All MAC Regions
#StockMarket #News
1
0
0
0
NEWS: ( OTC: #BSEM ) BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Study Evaluating the Value of Vendaje Compared to the Standard of Care for Non-Healing Diabetic Foot Ulcers
#StockMarket #News
1
0
0
0